Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Tolerability of concurrent external beam radiotherapy and [177Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial)

Fig. 1

Example of response of [177Lu]Lu-PSMA-617 in a patient with metastatic castration-resistant prostate cancer. On the left side you see a [68 Ga]Ga-PSMA-11 PET maximal intensity projection (MIP) of a patient with metastatic prostate cancer in bone and lymph nodes. There is physiological accumulation in the salivary glands, kidneys, spleen, and to a much lower extent small and large bowel. On the right you also see a [68 Ga]Ga-PSMA-11 PET MIP from the same patient after two cycles of [177Lu]Lu-PSMA-617 which shows almost complete response

Back to article page